Sign In
Buy ALXN
$182.50
+0 (+0%)
At Close: May 27, 2022
Why Earnings Season Could Be Great for Alexion (ALXN)
08:27am, Wednesday, 29'th Jul 2020
Alexion (ALXN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
4 More Biotechs Break From IPO Starting Gate
10:07pm, Monday, 27'th Jul 2020
Inozyme Pharma is biggest gainer in first week as a public company Continue reading...
Strength in Alexion Pharmaceuticals May Be Temporary
07:25pm, Monday, 27'th Jul 2020
Alexion Pharmaceuticals is up sharply Monday but this strength only looks temporary. Let's check out the charts and indicators. In the updated daily bar chart of ALXN, below, we can see that the shar
Alexion, Novocure, ACADIA: Out Of Favor Health Care Stocks Poised For Gains
10:30am, Monday, 27'th Jul 2020
The performance of the healthcare sector has been mixed this year. While dental and surgery-related stocks have declined - as Covid-19 impacts sectors that require a close person to person contact, co
Alexion, Novocure, ACADIA: Out Of Favor Health Care Stocks Poised For Gains
12:00am, Monday, 27'th Jul 2020
The performance of the healthcare sector has been mixed this year. While dental and surgery-related stocks have declined - as Covid-19 impacts sectors that require a close person to person contact, co
The Week Ahead In Biotech: Spotlight On GW Pharma, Ultragenyx FDA Decisions, Pfizer Earnings
12:00am, Sunday, 26'th Jul 2020
Biotech stocks moved lower in the week ended July 26, as the broader market weakness and sector-specific developments pressured stocks.
Although there were promising updates from...
Alexion (ALXN) to Report Q2 Earnings: What's in the Cards?
05:13pm, Friday, 24'th Jul 2020
Alexion (ALXN) will provide financial and corporate updates when it releases second-quarter 2020 results on Jul 30.
Rising Risk? Here's What You Can Buy
03:21pm, Friday, 24'th Jul 2020
Volatility caused by dismal economic data creates opportunities. Our overbought reading is heating up, suggesting you proactively pick entry points.
Alexion (ALXN) to Report Q2 Earnings: What's in the Cards?
01:13pm, Friday, 24'th Jul 2020
Alexion (ALXN) will provide financial and corporate updates when it releases second-quarter 2020 results on Jul 30.
Earnings Preview: Alexion Pharmaceuticals (ALXN) Q2 Earnings Expected to Decline
04:32pm, Thursday, 23'rd Jul 2020
Alexion (ALXN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Alexion Pharmaceuticals (ALXN) Q2 Earnings Expected to Decline
12:32pm, Thursday, 23'rd Jul 2020
Alexion (ALXN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Vident Investment Advisory LLC Has $1.56 Million Stock Position in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)
06:22am, Wednesday, 22'nd Jul 2020
Vident Investment Advisory LLC raised its position in shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) by 110.0% in the second quarter, according to its most recent filing with the SEC. The firm
X-Chem Announces Achievement of Milestone In Orexia Collaboration
12:00am, Wednesday, 22'nd Jul 2020
Orexia has exclusively licensed a small molecule Orexin OX2R agonist program from X-Chem's DNA-encoded libraries
Healthcare Dashboard For July
12:35pm, Tuesday, 21'st Jul 2020
A dashboard with metrics of value, quality and momentum by industries. Value and quality scores relative to historical averages.
IPO Update: Annexon Proposes IPO Terms
02:32pm, Monday, 20'th Jul 2020
Annexon has filed to raise $150 million in an IPO of its common stock. The firm is developing treatments for autoimmune and neurodegenerative diseases.
